# Levosimendan

## Simdax inj 12.5mg/5mL

##### 臨採

| TAH Drug Code      | [ISIMD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ISIMD)                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Short-term treatment of acutely decompensated severe chronic heart failure (ADHF) wherein conventional therapy is not sufficient & in cases where inotropic support is appropriate.                                                                                                                                                                                                                                             |
| Dosing             | For the short-term treatment of patients with acute decompensated heart failure when conventional therapies are insufficient and inotropic support is appropriate Adults: IV: Initial: 6 to 12 mcg/kg infused over 10 minutes. Maintenance: 0.05 to 0.1 mcg/kg/minute by continuous infusion for 24hr only.                                                                                                                     |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Contraindicated in patients who are allergic to levosimendan or racemic simendan or any of its excipients. Contraindicated in patients with significant mechanical obstruction affecting ventricular filling or outflow, or both. Contraindicated in patients with severe renal impairment (creatinine clearance less than 30 mL/min) and liver dysfunction. Contraindicated in patients with a history of Torsades de Pointes. |
| Adverse Effects    | Headache; ventricular tachycardia; hypotension. Hypokalaemia; insomnia; dizziness; atrial fibrillation, tachycardia, ventricular extrasystoles, cardiac failure, myocardial ischaemia, extrasystoles; nausea, constipation, diarrhoea, vomiting; decreased Hb.                                                                                                                                                                  |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/levosimendan-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                               |

